Active Ingredient: ELACESTRANT DIHYDROCHLORIDE
Proprietary Name: ORSERDU
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 345MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N217639
Product Number: 002
Approval Date: Jan 27, 2023
Applicant Holder Full Name: STEMLINE THERAPEUTICS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
